Survey of modalities of toxicity assessment and reporting in noncomparative prospective studies of chemotherapy in breast cancer

Journal of Clinical Oncology

Volumn 20, Issue 1, 2002, Pages 52-57

  Perrone, Francesco ^a   De Maio, Ermelinda ^a   Maione, Paolo ^a   Di Maio, Massimo ^a   Ottaiano, Alessandro ^a   Pensabene, Matilde ^a   Di Lorenzo, Giuseppe ^a   Lombardi, Alessandra Vernaglia ^a   Gallo, Ciro ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; BLOOD TOXICITY; BREAST CANCER; CLINICAL TRIAL; DATA ANALYSIS; HUMAN; METHODOLOGY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PUBLICATION; RELIABILITY; STATISTICAL ANALYSIS; WORLD HEALTH ORGANIZATION;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CLINICAL TRIALS, PHASE II; HUMANS; TOXICITY TESTS;

EID: 0036138717     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.20.1.52     Document Type: Article

References (11)

1. Reporting results of cancer treatment
2. New guidelines to evaluate the response to treatment in solid tumor
3. Toxicity and response criteria of the Eastern cooperative oncology group
4. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and European Organization for Research and Treatment of Cancer (EORTC)
5. Bivariate sequential designs for phase II trials
6. Incorporating toxicity considerations into the design of two-stage phase II clinical trials
7. Assessing the reliability of two toxicity scales: Implication for interpreting toxicity data
8. Analysis of serial measurements in medical research
9. Content and quality of currently published phase II cancer trials
10. Completeness of safety reporting in randomized trials